Literature DB >> 6626419

Effects of tobacco smoking and oral contraceptive use on theophylline disposition.

M J Gardner, K M Tornatore, W J Jusko, R Kanarkowski.   

Abstract

The independent as well as interactive effects of chronic (greater than 6 months) oral contraceptive (OC) use and cigarette smoking on single-dose (4 mg/kg) theophylline disposition were assessed in 49 young, healthy women. Significant elevations (40%) in theophylline plasma clearance were found in women who smoked. OC use resulted in decreases in clearance of a similar magnitude (28%). These factors do not appear to interact with respect to theophylline disposition. The combination of main effects tended to cancel one another (clearance of 49.1 ml h-1 kg-1 ideal body weight for OC non-user, non-smoker, vs 49.7 ml h-1 kg-1 for OC user-smoker). Single dose exposure to OC in non-users did not significantly alter theophylline pharmacokinetics for the group as a whole. However, in the subgroup of smoking subjects, significant decreases in clearance were evident (P less than 0.05). Analogous results were found for half-life. Volume of distribution was slightly diminished in smokers, but was unaffected in OC users. Areas under the serum concentration-time (AUC) profiles of norgestrel and ethinyloestradiol were examined in 27 women as indices of OC exposure. The smallest values of theophylline clearance were found in the subjects with largest AUC of both OC steroids. Appropriate statistical analyses of data which are influenced by multiple factors are discussed. Special concern is needed when the factor partitioning process yields subgroups of unequal sizes.

Entities:  

Keywords:  Behavior; Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Family Planning; Hepatic Effects; Oral Contraceptives--side effects; Physiology; Research Methodology; Smoking--side effects

Mesh:

Substances:

Year:  1983        PMID: 6626419      PMCID: PMC1427996          DOI: 10.1111/j.1365-2125.1983.tb02161.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  Decreased theophylline half-life in cigarette smokers.

Authors:  H Jenne; H Nagasawa; R McHugh; F MacDonald; E Wyse
Journal:  Life Sci       Date:  1975-07-15       Impact factor: 5.037

2.  Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration.

Authors:  F Z Stanczyk; M Hiroi; U Goebelsmann; P F Brenner; M E Lumkin; D R Mishell
Journal:  Contraception       Date:  1975-09       Impact factor: 3.375

3.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

4.  High-pressure liquid chromatographic and spectrophotometric assays for theophylline in biological fluids.

Authors:  W J Jusko; A Poliszczuk
Journal:  Am J Hosp Pharm       Date:  1976-11

5.  Elevated caffeine and ethynylestradiol blood levels in hypertensive oral contraceptive users.

Authors:  B S Ahluwalia; P S Verma; L Greer; K L Khanna; C L Crocker
Journal:  Contraception       Date:  1977-04       Impact factor: 3.375

6.  Antigens from synthetic and natural estrogens: formation by conjugation with protein through a thiopropionic acid link.

Authors:  C E Cook; C R Tallent; H D Christensen
Journal:  Life Sci       Date:  1974-03-16       Impact factor: 5.037

7.  Effect of oral contraceptives on drug metabolism.

Authors:  D E Carter; J M Goldman; R Bressler; R J Huxtable; C D Christian; M W Heine
Journal:  Clin Pharmacol Ther       Date:  1974-01       Impact factor: 6.875

8.  Nature of the effect of caffeine on the drug-metabolizing enzymes.

Authors:  C Mitoma; L Lombrozo; S E LeValley; F Dehn
Journal:  Arch Biochem Biophys       Date:  1969-11       Impact factor: 4.013

9.  Effect of oral contraceptives on plasma clearance.

Authors:  D E Carter; R Bressler; M R Hughes; M R Haussler; D Christian; M W Heine
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

10.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05
View more
  20 in total

1.  Prediction of drug response and safety in clinical practice.

Authors:  Andrew A Monte; Kennon J Heard; Vasilis Vasiliou
Journal:  J Med Toxicol       Date:  2012-03

2.  Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.

Authors:  David R Plowchalk; Karen Rowland Yeo
Journal:  Eur J Clin Pharmacol       Date:  2012-01-19       Impact factor: 2.953

3.  Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

Authors:  B Bruguerolle; M Toumi; F Faraj; D Vervloet; H Razzouk
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Effect of cigarette smoke on pharmacokinetics of oral, intrarectal, or intravenous indomethacin in rats.

Authors:  T Yoshida; Y Gomita; R Oishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

6.  Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; C Baese; H T Heidemann; E E Ohnhaus; H M Schulte
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

Review 7.  Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Authors:  Gail D Anderson; Lingtak-Neander Chan
Journal:  Clin Pharmacokinet       Date:  2016-11       Impact factor: 6.447

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

9.  Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.

Authors:  Janne T Backman; Marika T Schröder; Pertti J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2007-10-23       Impact factor: 2.953

10.  Longitudinal effects of pregnancy on the pharmacokinetics of theophylline.

Authors:  M J Gardner; M Schatz; L Cousins; R Zeiger; E Middleton; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.